3. Objectives
At the conclusion of this presentation the
participant will be able to:
ā¢ Recognize hemorrhagic shock signs and
symptoms
ā¢ Explain the importance of early control of
hemorrhage in trauma patients
ā¢ Describe the management and ongoing evaluation
of hemorrhagic shock
ā¢ List the components of damage control
resuscitation
5. Time to Trauma Death
ā¢ 50% deaths occur at scene
within minutes:
ā¢ CNS injury 40-50%
ā¢ Hemorrhage 30-40%
ā¢ 50% after hospital arrival:
ā¢ 60% die within first 4 hrs
ā¢ 84% die within first 12 hrs
ā¢ 90% die within first 24 hrs
ā¢ Hemorrhage accounts for 50%
ā¢ Deaths in the first 24 hours
8. Trimodal Moving Toward
Bimodal Death Distribution
0
10
20
30
40
50
60
70
Immediate Early Late
Early deaths have now increased and
time shifted (now < 50 min)
compared to (historical of 2 hrs)
2hrs
50
min
Historical (Pre 2000) Current (Post 2000)
11. Injuries Prone to Hemorrhage
Vascular Solid Organ Bones
Aorta
Vena Cava
Spleen
Liver
Pelvis
Femur
Quickly Rule Out Blood Loss
Chest ā CXR / FAST
Abdomen - FAST
Pelvis ā Xray
Femur ā exam / Xray
12. ā¢ Humerus 750 ml
ā¢ Tibia 750 ml
ā¢ Femur 1500 ml
ā¢ Pelvis > 3 L
Fracture Associated Blood Loss
Associated Soft Tissue Trauma
Release of Cytokines
ā¢ Increased permeability
ā¢ Magnify fluid loss
13. Confounding Factors In Response
To Hemorrhage
ā¢ Patients age
ā¢ Pre-existing disease /
meds
ā¢ Severity of injury
ā¢ Access to care
ā¢ Duration of shock
ā¢ Amount prehospital fluid
ā¢ Presence of hypothermia
24. ATLS Classification of
Hemorrhagic Shock
CLASS I CLASS II CLASS III CLASS IV
BloodLoss (ml)
%
<750
15%
750-1500
15%-30%
1500-2000
30-40%
>2000
>40%
HR <100 >100 >120 >140
BP normal normal decrease decrease
PP normal decrease decrease decrease
RR 14-20 20-30 30-40 >35
UOP >30 20-30 5-15 negligible
CNS slightly
anxious
mildly
anxious
anxious
confused
confused
lethargic
25. Effects of Blood Volume Loss on Mean
Arterial Pressure in Classes of Shock
100
0
Aortic
Press
(mmHg)
50
0 2 4 6
Time (hours)
15%
25%
35%
45%
60%
I
II
III
IV
Transfusion
Compensated
Decompensated
Most die
by 6 hrs
26. ā¢ pH
ā¢ Serum Lactate
ā¢ Base Deficit
ā¢ Echocardiography
ā¢ Arterial Wave
Analsyis
ā¢ StO2 (NIRS)
ā¢ Mentation
ā¢ Skin Perfusion
ā¢ Pulse
ā¢ Blood Pressure
ā¢ Pulse Pressure
ā¢ Shock Index
ā¢ Urine Output
Initial
Assessment
Resuscitation
Endpoints
Assessment vs. Resuscitation Endpoints
Traditional vs. New
Acute vs. Ongoing
Static vs. Dynamic
Global vs. End Organ
27. Response Fluid Resuscitation
EVAL
Rapid
Response
Transient
Response
No
Response
Vital Signs Return to
normal
Transient
improvement
Remain
abnormal
Estimated
Blood
Loss
Minimal
(10-20%)
Moderate and
ongoing
(20-40%)
Severe (>40%)
Need for more
IV fluid
Low High High
Need for
Blood
Low
T&C
Moderate
Type Spec
Specific
Immediate
O Pos/Neg
OR Possibly Likely High
28. Value of Manual Vital Signs
GCS
Motor
Verbal
Pulse
Character
Most Predictive for Need of Life Saving Interventions
29. Rough BP Estimation from Pulse
60
70
80
80
ā¢ If you can palpate
this pulse, you
know the SBP is
roughly this number
30. Occult Hypoperfusion
State of O2 delivery
in the setting of grossly
normal physiologic criteria
Patients donāt suddenly deteriorate, rather we suddenly
noticeā¦
31. Changing Mentation
ā¢ Indicator of perfusion
ā¢ Affected by drugs &
alcohol
ā¢ Hypoxia/Head Injury
ā¢ Until proven otherwise
32. Skin Perfusion
ā¢ Pale, cool, mottled
ā¢ Vasoconstriction
ā¢ Most sensitive in
pediatrics
ā¢ Starts distal extremities
ā¢ Ascends towards trunk
ā¢ Capillary Refill
ā¢ Unreliable to measure
ā¢ Normal < 2 seconds
33. Blood Pressure
ā¢ BP response to volume loss
ā¢ Non-linear due to compensatory mechanisms
ā¢ Insensitive sign of early shock
ā¢ NTDB study
ā¢ SBP did not decrease < 90
ā¢ Until base deficit was > 20
ā¢ Infrequently & or inadequately monitored
ā¢ First BP should always be manual
ā¢ Automated BP overestimated by 10 mm Hg
34. Blood Pressure
ā¢ Systolic BP drop a late sign
ā¢ Systolic BP does not fall until:
ā¢ Adults 30% blood loss
ā¢ Pediatrics 40-45% blood loss
ā¢ SBP < 90 mm Hg: mortality approaches 65%
35. Beware Dismissal of Prehospital BP
Skepticism
Prehospital
Hypotension
Prehospital + ED
Hypotension
Strong Predictor
ā¢ Mortality
ā¢ Need for Operation
36. Hypotension Redefined?
The New Hypotension: SBP < 110
ā¢ Associated with onset of physiologic changes
ā¢ Use only to diagnose shock
ā¢ Not as resuscitation endpoint
ā¢ Base Deficit
ā¢ ICU Days
ā¢ Ventilator Days
ā¢ Complications
38. New SBP Sweet Spot for
Early Diagnosis of Shock?
60 70 80 90 100 110 120 130
90 100 110 120 130 140 150 160
Adult Trauma
Geriatric Trauma
39. Pulse Pressure
ā¢ Narrowed pulse pressure suggests
significant blood loss
ā¢ Result of increasing diastolic pressure from
compensatory catecholamine release
100/66 100/74 100/77 100/84
40. Pulse
ā¢ Lacks specificity alone
ā¢ Age dependent
ā¢ Affected by:
ā¢ Emotion
ā¢ Fever
ā¢ Pain
ā¢ Drugs
ā¢ Pulse & character
together more reliable
ā¢ Trended over time may?
have sensitivity
ā¢ When to be concerned?
80 90 100 110 > 120
Any patient who is
cool & tachycardic
is in shock until
proven otherwise
(ATLS)
41. Relative Bradycardia
(Paradoxical Bradycardia)
ā¢ Defined as Pulse < 90 with SBP < 90
ā¢ Occurs in up to 45% of all
hypotensive trauma
ā¢ Cause remains unclear:
ā¢ Sign of rapid & severe internal
bleeding?
ā¢ Increased vagal tone from blood in abd
cavity?
ā¢ Protective reflex designed to increase
diastolic filing in the presence of severe
hypovolemia?
42. Shock Index (SI)
ā¢ SI = HR / SBP
ā¢ Elevated early in shock
ā¢ Normal 0.5 - 0.7
ā¢ SI > 0.9 predicts:
ā¢ Acute hypovolemia in presence of normal HR & BP
ā¢ Marker of injury severity & mortality
ā¢ Caution in Geriatrics
ā¢ May underestimate shock due to higher baseline SBP
ā¢ Uses
ā¢ Prehospital use ā triage
ā¢ Predict risk for mass transfusion?
43. Urine Output
Adult 0.5 ml / kg / hour
Child 1.0 ml / kg / hour
Toddler 1.5 ml / kg / hour
Infant 2.0 ml / kg / hour
44. Pulmonary Artery Catheter
ā¢ Not advocated for
hemorrhagic shock
ā¢ Dynamic response of
the systems too slow to
guide therapy
ā¢ Use:
ā¢ May benefit geriatric
trauma
ā¢ Sepsis goal directed
therapy
Hemodynamic Monitoring
Central Venous Pressure
ā¢ Not advocated for
hemorrhagic shock
ā¢ Poor relationship
between CVP and
blood volume
ā¢ Unreliable for assessing
response to fluid
ā¢ Use:
ā¢ Acute air embolus
ā¢ Acute PE
ā¢ Rt Ventricular infarction
ā¢ Acute lung injury
45. Doppler Echocardiography
(Transthoracic or Transesophageal)
ā¢ Allows for physician
bedside assessment:
ā¢ Ventricular function
ā¢ Volume status
ā¢ Stroke volume
ā¢ Cardiac output
ā¢ Dependent on:
ā¢ Technology
investment
ā¢ Technical expertise
ā¢ Intra-observer
variability
ā¢ Excellent diagnostic
tool
ā¢ Poor monitoring
device
46. Physiologic Variability as Predictors
ā¢ Subtle patterns of variation produced by healthy
biological systems is normal
ā¢ Loss of this variability is seen in critical illness
ā¢ Early loss of HR variability predicts mortality in
trauma
47. Arterial Pressure Waveform Systems
ā¢ Measures pulse pressure & stroke volume
variation
ā¢ Reliable predictors of volume responsiveness
ā¢ Determines where the patient lies on their own
individual Starling curve
Examples of systems:
PiCCO (Phillips)
pulseCO (LiDCO,Ltd.)
FloTrac/Vigileo (Edwards)
48. Near Infrared Spectroscopy (NIRS)
Skeletal muscle StO2
ā¢ Measures hemoglobin oxygen
saturation in tissue
ā¢ Tracks systemic O2 delivery
ā¢ Continuously and Noninvasively
ā¢ Comparable results to BD and Lactate
ā¢ Predicts MSOF
ā¢ Predicts Mortality
ā¢ Research ongoing as
resuscitation endpoint
50. Hemoglobin / Hematocrit
ā¢ Unreliable estimation acute blood
loss
ā¢ Lag time of several hours
ā¢ Baseline value for comparison
only
51. Arterial pH
Acidosis - Serum pH < 7.20
Ongoing Marker of Severe Physiologic
Derangement
ā¢ Decreased cardiac contractility
ā¢ Decreased cardiac output
ā¢ Vasodilation and decreased BP
ā¢ Decreased hepatic and renal blood flow
52. Lactate
ā¢ Indirect measure of oxygen debt
ā¢ Normal value = 1.0 mEq/L
ā¢ Values > 1.0 correlate to magnitude of shock
ā¢ Lactate Levels > 5 = ā mortality
ā¢ Ability to clear lactate within 24 hours:
ā¢ Predictive of survival
ā¢ Inability to clear lactate within 12 hours:
ā¢ Predictive of multisystem organ failure
53. Base Deficit
ā¢ Sensitive measure of inadequate perfusion
ā¢ Normal range -3 to +3
ā¢ Run on blood gases
ā¢ Admission BD correlates to blood loss
ā¢ Worsening BD:
ā¢ Ongoing bleeding
ā¢ Inadequate volume replacement
55. International Normalized Ratio (INR)
ā¢ Test of clotting (extrinsic pathway)
ā¢ Internationally accepted method of reporting
prothrombin (PT) results worldwide
Population Value
Normal 0.8 - 1.2
Anticoagulant Use 2.0 - 3.0
Trauma > 1.5 = coagulopathy
56. Thromboelastogram (TEG)
ā¢ Measures global function of clotting components
ā¢ Dynamically: clot formation to clot dissolution
ā¢ Pattern recognition
57. TEG Uses
ā¢ Predicts need for transfusion
ā¢ Targets use of blood components
ā¢ Identify hyperfibrinolytic patients
ā¢ Assess LMWH monitoring in high risk ICU pts
ā¢ Assess impact of platelet inhibitors
(aspirin and Plavix) with Platelet Mapping
ā¢ Possibly the only method for detecting degree of
anticoagulation by Dabigatran (Pradaxa)
58. TEG
ā¢ Rapid, clinician operated, point of care test
ā¢ Allows for individualized quick monitoring
ā¢ Where used:
ā¢ ED, OR, Angio, ICU
ā¢ Flat screen monitors
ā¢ Project results in all areas
ā¢ Large volume of research coming that will
establish TEG protocols in trauma resuscitation
61. Is There a Shock Position?
ā¢ Dr. Friedrich Trendelenburg 1800ās
ā¢ To improve surgical exposure - pelvic organs
No Benefit in Shock
62. Mechanical Means of
Stopping Hemorrhage
Pelvic Binders
ā¢ Reduce pelvis volume
ā¢ Tamponade effect
Tourniquets
ā¢ Studied extensively
in war
ā¢ Good outcomes
ā¢ Safe and effective
63. Mechanical Means of
Stopping Hemorrhage
Hemostatic Dressings
ā¢ Research advancing quickly
ā¢ Made of volcanic rock, clay, shells
ā¢ Actions:
ā¢ Direct compression
ā¢ Activation of clotting
ā¢ Adhesion
ā¢ Utility
ā¢ Speed of application (under fire)
ā¢ Pliable, Z Fold conformation
64. IV Access Principles in Shock
ā¢ Fastest, simplest route best (antecubital)
ā¢ Large bore, short length (14-16 gauge, 2inch length)
ā¢ Flow limited by IV gauge & length not size of vein
Optimally
ā¢ Two people attempting simultaneously
ā¢ Two different sites (above & below diaphragm)
ā¢ Two to three sites required per major trauma
ā¢ Progression [PIV ā Femoral ā Subclavian]
ā¢ Consider Intraosseous (IO) early as rescue device
65. Avoid IV Access
ā¢ Injured limb
ā¢ Distal to possible vascular wound
ā¢ Femoral access with injury below diaphragm
66. IV Access in Shock
ā¢ Femoral Vein
ā¢ 8.5/9.0 French Introducer
ā¢ Side port removed ā flow
rate
ā¢ Out of the way of
intubation or chest
procedures
ā¢ Subclavian/Internal
Jug
ā¢ Higher risk
(pneumothorax)
ā¢ Lower success rate
ā¢ In chest injuries,
place on side of
injury
67. Intraosseous Devices
ā¢ Temporary access
ā¢ Children & adults
ā¢ Insert within 1 minute
ā¢ Manual or power drill
ā¢ Prox tibia/humerus/sternum
ā¢ Avoid fracture /injury sites
ā¢ Good for fluid/blood/meds
ā¢ Flow rates up to 125 mL/min w pressure bag
ā¢ Risk: extravasation ā compartment syndrome
68. Pre Hospital IV Placement in Trauma?
EAST 2009 Guideline
ā¢ No evidence to
support IV placement
at scene
ā¢ Enroute OK
ā¢ Limit 2 attempts ā I.O.
ā¢ Saline lock/Keep open
ā¢ Avoid continuous IV
ā¢ Use small boluses
(250cc)
ā¢ Titrate to palpable
radial
71. IVās & Fluid Distribution
Total Body Water = 60% of Total Body Wt
Intracellular (ICF) 2/3 Extracellular (ECF) 1/3
ISS IVS
75% 25%
D5W 90% 90% <10%
NS 0% 75% <25%
LF 0% 75% <25%
72. NS vs. LR
Normal Saline
ā¢ Na,Cl
ā¢ Fluid of choice for
blood
ā¢ Con:
ā¢ Hyperchloremic
acidosis
Lactated Ringers
ā¢ Na, Cl, K, Ca,
Lactate
ā¢ Fluid of choice per
ATLS
ā¢ Con:
ā¢ Immune modulation
74. Small Volume Resuscitation
Paradigm Shift
ā¢ Using hypertonic/hyperosmotic fluid
ā¢ Remains in vascular space longer
ā¢ Restores vascular volume
ā¢ Without flooding patient
ā¢ Started by military ā civilian trauma
Examples:
ā¢ Hetastarch (Hespan/Hextend)
ā¢ Hypertonic Saline (3% to 7.5%)
75. Small Volume Resuscitation:
Hetastarch/Hespan/Hextend
ā¢ Plasma volume expander
ā¢ 500cc hetastarch expands blood volume 800cc
ā¢ Safe and effective at 500cc bolus
ā¢ Cons:
ā¢ May cause coagulopathy in large doses (>2L dose)
ā¢ Renal tubular dysfunction concern
2-3 L LR
500ml
Hetastarch
Equivalent
76. Small Volume Resuscitation
Hypertonic Saline
Type:
3.0% and 7.5% Sodium Chloride
Action:
Rapidly pulls fluid from tissues into bloodstream
Stabilizes BP & CO and controls ICP
~
Results:
Large RCT unable to show survival benefit
250 ml
1 Liter
NS or LR
78. Packed Red Blood
Cells
Plasma Platelets
Action Carries Oxygen
No clotting factors
Coagulation
Factors
Aggregation
1 unit ~300 ml (Hct 55%) ~250 ml ~25 ml individual unit
~150 pooled unit
Dose ā Hgb by 1 g/dl
ā Hct by 3 %
In the non-bleeding pt
ā coags by 2.5%
(Need at least 4 u
for significant
change)
1 unit Apheresis (pooled)
ā 25,000-50,000 per u
Storage -4 C
Progression:
Emerg Uncrossmatched
(immediate)
Type Specific (20 min)
Cross Matched (60 min)
Non Trauma
Center
ā¢ Frozen
ā¢ thaw time
ā¢ 2 u in 30
minutes
Trauma Center
ā¢ Room Temp
ā¢ Good for 5
days
ā¢ Monitor
wastage
Room temp
Agitated
79. Blood Administration
Traditional
Management
Fluid Blood
Give 2 Liters
ā ā
Continue IVās
wide open
PRBC 5-10 u
ā
Wait for labs
ā
Plasma
ā
Platelets
Emerging
Management
Fluid Blood
Minimize 1:1 or 1:2
(Plasma: RBC)
Protocolize
ā
Massive
Transfusion
Protocol
87. Recombinant Factor VIIa
NovoSeven
ā¢ Refractory bleeding in
trauma
ā¢ Activates Extrinsic
Pathway
ā¢ Off label use in trauma
ā¢ Research Results in
Trauma:
ā¢ Numerous anecdotal
reports
ā¢ 1 RCT published trauma:
ā¢ ā blood use
ā¢ ā MSOF ā ARDS
ā¢ Trend toward ā
mortality
ā¢ No ā thrombotic events
Correct before use:
ā¢ Hypofibrinogenemia:
ā¢ Give Cryoprecipitate
ā¢ Thrombocytopenia
ā¢ Give Platelets
ā¢ Hypothermia
ā¢ Correct Temperature
ā¢ Acidosis
ā¢ Consider Bicarbonate
88. Factor VIIa
ā¢ Include in Massive Transfusion Protocol:
ā¢ Do not use to early or too late
ā¢ Administer between 8 - 20 PRBCās
ā¢ Recommended dose: 100 mcg/kg
ā¢ Expensive:
ā¢ 100mcg X 70kg =7,000mcg = $7,700
ā¢ Repeated at 1-2 hour intervals if required
89. Tranexamic acid (TXA)
ā¢ Derivative of AA Lysine - inhibits fibrinolysis
ā¢ Inexpensive ( $80/dose) and proven safety profile
ā¢ Cochrane review (2007) 53 RCTās Cardiac/Ortho
ā¢ Sig reduction in bleeding without thrombotic complications
ā¢ CRASH2 trial (2010) Prospective RCT, > 20,000 pts
ā¢ Stat sig 1.5% reduction in mortality (overall)
ā¢ Subgroup analysis (Severe bleeding & early admin)
ā¢ Reduced bleeding by 30% IF given within 1 hour
ā¢ MATTERs trial (2011) Camp Bastion in Afghanistan
ā¢ Marked improvement in survival in most severely injured
compared to those who did not receive it
ā¢ Soldiers to carry autoinjectors on battlefield
90. Tranexamic Acid (TXA)
Example Protocols
Military Protocol
ā¢ Give within 1-3 hours
of injury
ā¢ 1 unit of blood
ā¢ 1 Gm of Bolus of
TXA
ā¢ 1 Gm Infusion over 8
hrs
Oregon Health & Science
University Protocol
ā¢ MTP activated
ā¢ Pt has received > 4
units within 2 hours
ā¢ Give 1 Gm bolus
ā¢ Start 1 Gm drip over
8 hrs
100. Permissive Hypotension
ā¢ Restricted fluid
administration
ā¢ Avoid āpopping the
clotā
ā¢ Accepting limited
period (< 2 hours) of
suboptimum end organ
perfusion
ā¢ Titrate to Mean Arterial
Pressure (MAP)
101. Mean Arterial Pressure (MAP)
ā¢ Animal studies indicate a MAP of 50-60 as
a resuscitation target
40 50 60 70 80
Pop the Clot
Fatal Hypoperfusion
MAP
102. Human RCT Studies:
Permissive Hypotension
Bickell, 1994 NEJM
(Houston)
ā¢ Randomized trial (n=598)
ā¢ Penetrating hypotensive
ā¢ EMS study
Dutton, 2002 JT
(Baltimore)
ā¢ Randomized trial (n=110)
ā¢ Blunt + Penetrating
hypotensive
ā¢ Emergency Department study
EMS
Fluid
EMS
No Fluid
62%
Survival
70%
Survival
ED
SBP 80
ED
SBP 100
92%
Survival
92%
Survival
103. Permissive Hypotension
RCT Intraoperative
Morrison, 2011, J of T (Houston) Prelim Results
ā¢ n=90 Blunt & Pen, Hypotensive, To OR for chest or abd
ā¢ Maintaining target minimum MAP 50 vs. 65
ā¢ Results: Hypotensive resuscitation is safe
Decreased Coagulopathy and early death
106. Hemostatic Resuscitation
ā¢ Early diagnosis in ED
ā¢ 1:1 ratio (PRBC to FFP)
ā¢ Early frequent:
ā¢ Cryoprecipitate
ā¢ Platelets
ā¢ Minimal crystalloids
ā¢ Stop the bleeding
107. ATLS:
After 20 years of high volume fluid resuscitation
Chasing tachycardia
Using Crystalloid > Blood
Little evidence of improved survival
Blood Loss
Current consensus:
Damage Control Resuscitation
ā¢ Permissive Hypotension
ā¢ Hemostatic Resuscitation
ā¢ Damage Control Surgery
112. Identifying The Patient
At Risk In ED
ā¢ High ISS
ā¢ SI > 0.9
ā¢ SBP < 90 mm Hg
ā¢ Acidosis Base Deficit > 6
ā¢ Hypothermia T < 35C (95 F)
ā¢ INR > 1.5
ā¢ Elevated Lactate
Required Labs
For Major
Activations:
ā¢ ABG
ā¢ BD
ā¢ Lactate
ā¢ INR
113. Putting It All Together
Hemorrhaging
(Non TBI)
SBP 80-90
TBI SBP > 90
Hemorrhage
+ TBI
No
Recommendation
114. Summary
ā¢ Assess for coagulopathy early
ā¢ LR is fluid of choice in trauma
ā¢ Utilize Massive Transfusion Protocol
ā¢ Small volume resuscitation techniques
ā¢ Consider Tranexamic acid and Factor VIIa
ā¢ Correct acidosis and hypothermia
ā¢ STOP THE BLEEDING!